Dihomo-γ-Linolenic Acid | B2751

Dihomo-γ-Linolenic Acid (DGLA, 20:3), an elongation product of γ-linolenic acid (18:3), is rapidly metabolized by fatty acid desaturases to produce arachidonic acid (20:4). DGLA is metabolized through the cyclooxygenase pathway to produce 1-series prostaglandins, including PGE1. DGLA also inhibits several key cellular processes associated with atherosclerosis.

Dihomo-γ-Linolenic Acid (DGLA, 20:3), an elongation product of γ-linolenic acid (18:3), is rapidly metabolized by fatty acid desaturases to produce arachidonic acid (20:4). DGLA is metabolized through the cyclooxygenase pathway to produce 1-series prostaglandins, including PGE1. DGLA also inhibits several key cellular processes associated with atherosclerosis.

B2751 | Dihomo-γ-Linolenic Acid DataSheet

Alternate Name/Synonyms: 8Z,11Z,14Z-eicosatrienoic acid,DGLA

Appearance: Liquid

Formulation: A solution in ethanol

CAS Number: 1783-84-2

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₀H₃₄O₂

Molecular Weight: 306.5

Cell-Permeable?: TRUE

Purity: ≥98%

Solubilities:

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: An anti-atherogenic agent

MDL Number: MFCD00065721

PubChem CID: 5280581

SMILES: CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O

InChi: InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-

InChi Key: HOBAELRKJCKHQD-QNEBEIHSSA-N